These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8578812)

  • 1. Mice immunized with a dengue type 2 virus E and NS1 fusion protein made in Escherichia coli are protected against lethal dengue virus infection.
    Srivastava AK; Putnak JR; Warren RL; Hoke CH
    Vaccine; 1995 Sep; 13(13):1251-8. PubMed ID: 8578812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the protective efficacy of a recombinant dengue envelope B domain fusion protein against dengue 2 virus infection in mice.
    Simmons M; Nelson WM; Wu SJ; Hayes CG
    Am J Trop Med Hyg; 1998 May; 58(5):655-62. PubMed ID: 9598457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization of monkeys with baculovirus-dengue type-4 recombinants containing envelope and nonstructural proteins: evidence of priming and partial protection.
    Eckels KH; Dubois DR; Summers PL; Schlesinger JJ; Shelly M; Cohen S; Zhang YM; Lai CJ; Kurane I; Rothman A
    Am J Trop Med Hyg; 1994 Apr; 50(4):472-8. PubMed ID: 8166355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dengue-2 Envelope fragment inserted within the structure of the P64k meningococcal protein carrier enables a functional immune response against the virus in mice.
    Hermida L; Rodríguez R; Lazo L; Silva R; Zulueta A; Chinea G; López C; Guzmán MG; Guillén G
    J Virol Methods; 2004 Jan; 115(1):41-9. PubMed ID: 14656459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of C-terminally truncated dengue 2 and dengue 3 virus envelope glycoproteins: processing in insect cells and immunogenic properties in mice.
    Delenda C; Staropoli I; Frenkiel MP; Cabanié L; Deubel V
    J Gen Virol; 1994 Jul; 75 ( Pt 7)():1569-78. PubMed ID: 8021588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing biosynthesis and secretion of premembrane and envelope proteins by the chimeric plasmid of dengue virus type 2 and Japanese encephalitis virus.
    Chang GJ; Hunt AR; Holmes DA; Springfield T; Chiueh TS; Roehrig JT; Gubler DJ
    Virology; 2003 Feb; 306(1):170-80. PubMed ID: 12620809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dengue-1 virus envelope glycoprotein gene expressed in recombinant baculovirus elicits virus-neutralizing antibody in mice and protects them from virus challenge.
    Putnak R; Feighny R; Burrous J; Cochran M; Hackett C; Smith G; Hoke C
    Am J Trop Med Hyg; 1991 Aug; 45(2):159-67. PubMed ID: 1877710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carboxy-terminally truncated Dengue 4 virus envelope glycoprotein expressed in Pichia pastoris induced neutralizing antibodies and resistance to Dengue 4 virus challenge in mice.
    Muné M; Rodríguez R; Ramírez R; Soto Y; Sierra B; Rodríguez Roche R; Marquez G; Garcia J; Guillén G; Guzmán MG
    Arch Virol; 2003 Nov; 148(11):2267-73. PubMed ID: 14579183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A fragment of the envelope protein from dengue-1 virus, fused in two different sites of the meningococcal P64k protein carrier, induces a functional immune response in mice.
    Hermida L; Rodríguez R; Lazo L; Bernardo L; Silva R; Zulueta A; López C; Martín J; Valdés I; del Rosario D; Guillén G; Guzmán MG
    Biotechnol Appl Biochem; 2004 Feb; 39(Pt 1):107-14. PubMed ID: 12887334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization of mice with recombinant vaccinia virus expressing authentic dengue virus nonstructural protein NS1 protects against lethal dengue virus encephalitis.
    Falgout B; Bray M; Schlesinger JJ; Lai CJ
    J Virol; 1990 Sep; 64(9):4356-63. PubMed ID: 2143542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amino acid changes in the recombinant Dengue 3 Envelope domain III determine its antigenicity and immunogenicity in mice.
    Zulueta A; Martín J; Hermida L; Alvarez M; Valdés I; Prado I; Chinea G; Rosario D; Guillén G; Guzmán MG
    Virus Res; 2006 Oct; 121(1):65-73. PubMed ID: 16781791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yellow fever virus/dengue-2 virus and yellow fever virus/dengue-4 virus chimeras: biological characterization, immunogenicity, and protection against dengue encephalitis in the mouse model.
    Chambers TJ; Liang Y; Droll DA; Schlesinger JJ; Davidson AD; Wright PJ; Jiang X
    J Virol; 2003 Mar; 77(6):3655-68. PubMed ID: 12610141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mice immunized with recombinant vaccinia virus expressing dengue 4 virus structural proteins with or without nonstructural protein NS1 are protected against fatal dengue virus encephalitis.
    Bray M; Zhao BT; Markoff L; Eckels KH; Chanock RM; Lai CJ
    J Virol; 1989 Jun; 63(6):2853-6. PubMed ID: 2724416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary evaluation of DNA vaccine candidates encoding dengue-2 prM/E and NS1: their immunity and protective efficacy in mice.
    Lu H; Xu XF; Gao N; Fan DY; Wang J; An J
    Mol Immunol; 2013 Jun; 54(2):109-14. PubMed ID: 23270684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dengue type-2 virus envelope protein made using recombinant baculovirus protects mice against virus challenge.
    Feighny R; Burrous J; Putnak R
    Am J Trop Med Hyg; 1994 Mar; 50(3):322-8. PubMed ID: 8147490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-level expression of recombinant dengue virus type 2 envelope domain III protein and induction of neutralizing antibodies in BALB/C mice.
    Zhang ZS; Yan YS; Weng YW; Huang HL; Li SQ; He S; Zhang JM
    J Virol Methods; 2007 Aug; 143(2):125-31. PubMed ID: 17532481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification of native dengue-2 viral proteins and the ability of purified proteins to protect mice.
    Feighny R; Burrous J; McCown J; Hoke C; Putnak R
    Am J Trop Med Hyg; 1992 Oct; 47(4):405-12. PubMed ID: 1443338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA priming E and NS1 constructs--homologous proteins boosting immunization strategy to improve immune response against dengue in mice.
    Mellado-Sánchez G; García-Cordero J; Luria-Pérez R; Lázaro-Olan L; Santos-Argumedo L; Gutiérrez-Castañeda B; Estrada-García I; Cedillo-Barrón L
    Viral Immunol; 2005; 18(4):709-21. PubMed ID: 16359237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short report: Antibody responses of mice immunized with a tetravalent dengue recombinant protein subunit vaccine.
    Simmons M; Murphy GS; Hayes CG
    Am J Trop Med Hyg; 2001 Aug; 65(2):159-61. PubMed ID: 11508393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA vaccines against dengue virus based on the ns1 gene: the influence of different signal sequences on the protein expression and its correlation to the immune response elicited in mice.
    Costa SM; Azevedo AS; Paes MV; Sarges FS; Freire MS; Alves AM
    Virology; 2007 Feb; 358(2):413-23. PubMed ID: 17020777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.